Name | NOVAMEDIKA, OOO |
|---|
INN | 7718886050 |
|---|
KPP | 771401001 |
|---|
OGRN | 1127746365119 |
|---|
OKPO | 9774097 |
|---|
Address | 125124, G.MOSKVA, ul. 3-ya yamskogo polya, d. 18 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 72.19 | Core activity | Research and experimental development on natural sciences and engineering Other | | 10.89.4 | Additional activity | Manufacture of food enzymes | | 20.13 | Additional activity | Manufacture of other inorganic basic chemicals | | All types of activities | | 20.14 | Additional activity | Manufacture of other inorganic basic chemicals | | 21.1 | Additional activity | Pharmaceutical substances | | 46.12.3 | Additional activity | Activity of agents in wholesale trade of industrial and technical chemicals, fertilizers and agrochemicals | | 46.18.1 | Additional activity | Agents specialized in the wholesale trade of pharmaceutical products, products used for medical purposes, perfume and cosmetics, including soap and detergents | | 46.45 | Additional activity | Wholesale of detergents and cleaners | | 46.46 | Additional activity | Wholesale of pharmaceutical goods | | 46.75 | Additional activity | Wholesale trade of chemical products | | 64.19 | Additional activity | Credit institutions with special functions | | 71.20.1 | Additional activity | Technical testing and analysis | | 71.20.9 | Additional activity | Activities for technical control, testing and other analysis |
Registration date | 10.05.2012 |
|---|
Registering department | Mezhrayonnaya inspektsiya Federal'noy nalogovoy sluzhby N 46 po g. Moskve |
|---|
|
NOVAMEDIKA, OOO (Moscow; INN 7718886050) was registered on 10 May 2012. The company's authorized capital as of July 1, 2012 was 648263648 rub. Principal activities of NOVAMEDIKA, OOO: research and experimental development on natural sciences and engineering other (72.19), manufacture of food enzymes (10.89.4), manufacture of other inorganic basic chemicals (20.13). |
Economic indicators2023
Net loss (RAS) of NOVAMEDIKA, OOO dropped over 2023 by 19.55% to 170.70 million RUB from 212.18 million RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period 1.65 times to 471.64 million RUB from 285.70 million RUB over 2022; cost of goods sold grew by 21.51% to 263.68 million RUB from 217.01 million RUB; sales loss decreased by 8.48% to 281.63 million RUB from 307.74 million RUB. 2022
Net loss (RA) of NOVAMEDIKA, OOO made up 212.18 million RUB over 2022 compared to net profit of 515.97 million RUB over 2021, the company informed. Revenue increased in the accounting period by 9.43% to 285.70 million RUB from 261.08 million RUB over 2021; cost of goods sold grew by 28.66% to 217.01 million RUB from 168.67 million RUB; sales loss decreased by 9.23% to 307.74 million RUB from 339.02 million RUB. 2021
Net profit (RAS) of NOVAMEDIKA, OOO grew over 2021 1.54 times to 515.97 million RUB from 334.47 million RUB over 2020, the company informed. Revenue decreased in the accounting period by 27.71% to 261.08 million RUB from 361.17 million RUB in 2020; cost of goods sold decreased by 34.52% to 168.67 million RUB from 257.60 million RUB; sales loss grew by 34.21% to 339.02 million RUB from 252.60 million RUB. 2020
Net profit (RAS) of NOVAMEDIKA, OOO made up 334.47 million RUB over 2020 compared to net loss of 596.73 million RUB over 2019, the company informed. Revenue decreased in the accounting period by 39.86% to 361.17 million RUB from 600.50 million RUB in 2019; cost of goods sold decreased by 38.90% to 257.60 million RUB from 421.60 million RUB; sales loss decreased 3.04 times to 252.60 million RUB from 768.68 million RUB. 2019
Net loss (RAS) of NOVAMEDIKA, OOO dropped over 2019 by 42.70% to 596.73 million RUB from 1.04 billion RUB KAgent.Entities.Balance, the company informed. Revenue decreased in the accounting period 3.27 times to 600.50 million RUB from 1.97 billion RUB in 2018; cost of goods sold decreased 3.95 times to 421.60 million RUB from 1.66 billion RUB; sales loss decreased by 9.72% to 768.68 million RUB from 851.42 million RUB. 2018
Net loss (RAS) of NOVAMEDIKA, OOO increased by 35.13% to 1.04 billion RUB from 770.62 million RUB over 2017, the company informed. Revenue increased in the accounting period by 33.99% to 1.97 billion RUB from 1.47 billion RUB over 2017; cost of goods sold grew by 44.93% to 1.66 billion RUB from 1.15 billion RUB; sales loss grew by 49.91% to 894.28 million RUB from 596.56 million RUB. 2017
Net loss (RAS) of NOVAMEDIKA, OOO increased by 8.32% to 770.62 million RUB from 711.44 million RUB over 2016, the company informed. Revenue increased in the accounting period by 42.60% to 1.47 billion RUB from 1.03 billion RUB over 2016; cost of goods sold grew by 32.20% to 1.15 billion RUB from 868.25 million RUB; sales loss decreased by 24.22% to 596.56 million RUB from 787.23 million RUB. 2016
Net loss (RAS) of NOVAMEDIKA, OOO dropped over 2016 by 33.34% to 711.44 million RUB from 1.07 billion RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period 2.72 times to 1.03 billion RUB from 378.62 million RUB over 2015; cost of goods sold grew 3.16 times to 868.25 million RUB from 274.91 million RUB; sales loss decreased by 11.77% to 787.23 million RUB from 892.23 million RUB. 2014
Net loss (RAS) of NovaMedika, OOO increased 1.81 times to 538.71 million RUB from 297.47 million RUB over 2013, the company informed. Sales loss grew by 48.69% to 527.28 million RUB from 354.62 million RUB. 2013
Net loss (RAS) of NovaMedika, OOO increased 1.70 times to 297.47 million RUB from 174.74 million RUB over 2012, the company informed. Sales loss grew 1.68 times to 354.62 million RUB from 210.94 million RUB. 2012
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|